Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease

被引:100
|
作者
Kalender, B
Ozdemir, AC
Koroglu, G
机构
[1] Kocaeli Univ, Fac Med, Div Nephrol, Kocaeli, Turkey
[2] Kocaeli Univ, Fac Med, Div Psychiat, Kocaeli, Turkey
来源
NEPHRON CLINICAL PRACTICE | 2006年 / 102卷 / 3-4期
关键词
depression; C-reactive protein; hypoalbuminemia; chronic kidney disease; end-stage renal disease;
D O I
10.1159/000089669
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Depression, which is the most common psychological disorder among patients with end-stage renal disease ( ESRD), is commonly associated with poor oral intake which can aggravate anemia and malnutrition in chronic dialysis patients. The objective of this study is to explore the association between depression and C-reactive protein (CRP), ferritin, serum albumin and hemoglobin/ hematocrit in patients with chronic kidney disease (CKD) and ESRD. Methods: Sixty-eight patients on hemodialysis (HD), 47 patients on continuous ambulatory peritoneal dialysis ( CAPD) and 26 patients with CKD on conservative management were enrolled in this study. All patients were evaluated for the presence of depression using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I Disorders-Clinician Version (SCID-CV). The severity of depression was evaluated by means of the Beck Depression Inventory ( BDI). Serum CRP ( nephelometric method), ferritin (immunometric method), albumin (bromcresol green technique), hemoglobin, and hematocrit levels were measured. Results: A total of 34 of 141 patients (24.1%) had depression. The mean BDI score was higher in depressive patients compared to nondepressive patients. In HD patients the frequency of depression and CRP and ferritin levels were higher than in other groups. Patients with depression had lower hemoglobin, hematocrit and serum albumin levels and higher CRP and ferritin levels than patients without depression. The BDI score showed a positive correlation with serum CRP and ferritin levels, but a negative correlation with the serum albumin level. Conclusions: We observed that CKD and ESRD patients with anemia, hypoalbuminemia and higher serum CRP and ferritin concentrations should be evaluated for depression after potential somatic causes have been eliminated. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:C115 / C121
页数:7
相关论文
共 50 条
  • [41] Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease
    Golembiewska, Edyta
    Machowska, Anna
    Stenvinkel, Peter
    Lindholm, Bengt
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (12) : 1232 - 1243
  • [42] Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease
    Khurana, Mona
    Silverstein, Douglas M.
    PEDIATRIC NEPHROLOGY, 2015, 30 (12) : 2073 - 2084
  • [43] Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar
    Wen, Chi Pang
    Matsushita, Kunihiro
    Coresh, Josef
    Iseki, Kunitoshi
    Islam, Muhammad
    Katz, Ronit
    McClellan, William
    Peralta, Carmen A.
    Wang, HaiYan
    de Zeeuw, Dick
    Astor, Brad C.
    Gansevoort, Ron T.
    Levey, Andrew S.
    Levin, Adeera
    KIDNEY INTERNATIONAL, 2014, 86 (04) : 819 - 827
  • [44] Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study
    Kieneker, Lyanne M.
    Hartmann, Oliver
    Bergmann, Andreas
    de Boer, Rudolf A.
    Gansevoort, Ron T.
    Joosten, Michel M.
    Struck, Joachim
    Bakker, Stephan J. L.
    BIOMARKERS, 2018, 23 (05) : 474 - 482
  • [45] Artificial Intelligence for Risk Prediction of End-Stage Renal Disease in Sepsis Survivors with Chronic Kidney Disease
    Lee, Kuo-Hua
    Chu, Yuan-Chia
    Tsai, Ming-Tsun
    Tseng, Wei-Cheng
    Lin, Yao-Ping
    Ou, Shuo-Ming
    Tarng, Der-Cherng
    BIOMEDICINES, 2022, 10 (03)
  • [46] Depression in end-stage renal disease patients: A critical review
    Kimmel, Paul L.
    Cukor, Daniel
    Cohen, Scott D.
    Peterson, Rolf A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (04) : 328 - 334
  • [47] INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS
    Abdel-Messeih, Phebe Lotfy
    Alkady, Manal Mohamed
    Nosseir, Neveen Mostafa
    Tawfik, Mohamed Said
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (04) : 481 - 487
  • [48] New markers of accelerated atherosclerosis in end-stage renal disease
    Rattazzi, M
    Puato, M
    Faggin, E
    Bertipaglia, B
    Grego, F
    Pauletto, P
    JOURNAL OF NEPHROLOGY, 2003, 16 (01) : 11 - 20
  • [49] Thyroid disease in end-stage renal disease
    Rhee, Connie M.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06) : 621 - 630
  • [50] The continuum of chronic kidney disease and end-stage renal disease: Challenges and opportunities for chronic peritoneal dialysis in the United States
    Mehrotra, Rajnish
    PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 (02): : 125 - 130